(c) 2024 PillSync.com

nabumetone 750 MG Oral Tablet

INDICATIONS AND USAGE Carefully consider the potential benefits and risks of Nabumetone Tablets USP and other treatment options before deciding to use Nabumetone Tablets USP. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS ). Nabumetone Tablets USP are indicated for relief of signs and symptoms of osteoarthritis and rheumatoid arthritis.

Teva Pharmaceuticals USA, Inc.


4 years ago OVAL BROWN 93 16 nabumetone 750 MG Oral Tablet

OVAL BROWN 93 16

4 years ago OVAL BROWN 93 16 nabumetone 750 MG Oral Tablet

93 16 OVAL BROWN

HOW SUPPLIED Nabumetone Tablets USP are available as follows: 500 mg: white, oval-shaped, unscored, film-coated tablet debossed with the numbers “93” on one face of the tablet and “15” on the other. They are available in bottles of 100 tablets (NDC 0093-1015-01) and 1000 tablets (NDC 0093-1015-10). 750 mg: beige, oval-shaped, unscored, film-coated tablet debossed with the numbers “93” on one face of the tablet and “16” on the other. They are available in bottles of 100 tablets (NDC 0093-1016-01) and 1000 tablets (NDC 0093-1016-10). Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure (as required). KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN. Manufactured In Israel By: TEVA PHARMACEUTICAL IND. LTD. Jerusalem, 9777402, Israel Manufactured For: TEVA PHARMACEUTICALS USA, INC. North Wales, PA 19454 Rev. U 7/2015


More pills like OVAL 93 16












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site